Kate Wheeler

Clinical, Biologic, and Prognostic Differences on the Basis of Primary Tumor Site in Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

Kieuhoa T. Vo, Katherine K. Matthay, John Neuhaus et al. · Journal of Clinical Oncology · 2014 · 209 citations · Full text

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity

Francis Mussai, Sharon A. Egan, Stuart Hunter et al. · Cancer Research · 2015 · 106 citations · Full text

T-regulatory Cell, Immunology, Pathology +18

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience

Kate Wheeler, Sue Richards, Clifford C. Bailey et al. · British Journal of Haematology · 1998 · 105 citations

Hematological Malignancy, Lymphoid Neoplasia, Transplantation +14

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

Gudrun Schleiermacher, Jean Michon, Agnès Ribeiro et al. · British Journal of Cancer · 2011 · 98 citations · Full text

Bone marrow transplantation versus chemotherapy in the treatment of very high–risk childhood acute lymphoblastic leukemia in first remission: results from Medical Research Council UKALL X and XI

Kate Wheeler, Susan Richards, Clifford C. Bailey et al. · Blood · 2000 · 66 citations